Supernus Acquisitions

Supernus has acquired 4 companies and its latest acquisition was Adamas Pharmaceuticals, Inc. on Oct 2021

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Adamas Pharmaceuticals, Inc.

Oct 2021

Source »
$400M
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
US WorldMeds, LLC

Apr 2020

Source »
$300M
US WorldMeds is a pharmaceutical company that develops and commercializes therapies for the treatment of idiopathic parkinson's disease.
Biscayne NeuroTherapeutics

Sep 2018

Source »
$15M
Biscayne is a clinical-stage​ biotechnology company developing drugs for the treatment of neurological disorders.

-

Drug Formulation Business,Shire Laboratories Inc

Jan 2006

Source »
undisclosed
-

Frequently Asked Questions about Supernus

  1. What companies did Supernus acquire?

    Companies acquired by Supernus include Adamas, US WorldMeds and Biscayne NeuroTherapeutics
  2. How many acquisitions does Supernus have?

    Supernus has acquired 4 companies including Adamas, US WorldMeds and Biscayne NeuroTherapeutics.
  1. How many acquisitions did Supernus make in 2021?

    In 2021 Supernus acquired 1 companies including Adamas.